Gd-DTPA is best described as which type of agent used in MRI?

Prepare for the Diagnostic and Therapeutic Modalities Test. Utilize flashcards and multiple-choice questions with detailed hints and explanations. Ensure success on your exam!

Multiple Choice

Gd-DTPA is best described as which type of agent used in MRI?

Explanation:
Gadolinium-DTPA is a gadolinium-based contrast agent used in MRI. Gadolinium is a paramagnetic metal that, when chelated with DTPA, becomes safer to inject intravenously. After administration, it shortens the T1 relaxation time of nearby water protons, causing enhanced signals on T1-weighted images. This makes abnormalities such as tumors, inflammation, or blood–brain barrier disruption easier to see and differentiate from normal tissue. It is not a sedative, nor a radiographic dye used for X-ray/CT, nor a fluoroscopic contrast agent. While generally well tolerated, it should be used with care in patients with severe kidney impairment due to a small risk of nephrogenic systemic fibrosis, and renal function is typically evaluated beforehand.

Gadolinium-DTPA is a gadolinium-based contrast agent used in MRI. Gadolinium is a paramagnetic metal that, when chelated with DTPA, becomes safer to inject intravenously. After administration, it shortens the T1 relaxation time of nearby water protons, causing enhanced signals on T1-weighted images. This makes abnormalities such as tumors, inflammation, or blood–brain barrier disruption easier to see and differentiate from normal tissue. It is not a sedative, nor a radiographic dye used for X-ray/CT, nor a fluoroscopic contrast agent. While generally well tolerated, it should be used with care in patients with severe kidney impairment due to a small risk of nephrogenic systemic fibrosis, and renal function is typically evaluated beforehand.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy